19 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35321689 | Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p. | 2022 Mar 23 | 2 |
2 | 23163346 | The evaluation of cisplatin effect on tubular function in children on chemotherapy. | 2013 Feb | 1 |
3 | 23287709 | In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. | 2013 Mar 13 | 1 |
4 | 21329608 | [Monitoring of the renal function changes during chemotherapy based on high-dose cisplatin in patients with lung cancer]. | 2002 Oct 20 | 1 |
5 | 9838911 | [Early phase II study of FK352 in cisplatin-induced nephropathy. Niigata Prefecture FK352 Study Group]. | 1998 Nov | 1 |
6 | 9246969 | Cisplatin-induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels. | 1997 Jul | 1 |
7 | 8667622 | Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells. | 1996 Jul | 1 |
8 | 7520380 | Urinary endothelin-1-like immunoreactivity in young male patients with testicular cancer treated by cis-platinum: comparison with other urinary parameters. | 1994 Jun | 1 |
9 | 2178884 | Cisplatin nephrotoxicity: experimental and clinical studies. | 1990 Feb | 1 |
10 | 2459938 | [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration]. | 1988 May | 2 |
11 | 3063983 | Serum beta 2-microglobulin after five-day administration of cisplatin. | 1988 | 1 |
12 | 3278818 | Relationship between urine beta-2-microglobulin and platinum levels during cisplatin treatment. | 1988 Jan | 3 |
13 | 3278937 | Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II). | 1988 Feb | 2 |
14 | 3280153 | Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. | 1988 | 1 |
15 | 3542269 | Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide. | 1986 | 1 |
16 | 3794453 | [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. | 1986 Nov | 2 |
17 | 3908127 | Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment. | 1985 | 1 |
18 | 3922640 | Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment? | 1985 | 1 |
19 | 6170429 | Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity. | 1981 Nov-Dec | 1 |